Navigation Links
UC Riverside entomologist to study diseases transmitted by ticks
Date:8/4/2011

RIVERSIDE, Calif. Summer for most people means time spent outdoors, which could also mean increased exposure to bugs and, possibly, arthropod-borne diseases, such as "rickettsial diseases" infectious diseases spread by bacteria, which, generally, are transmitted by lice, fleas, ticks and mites.

Now a $1.6 million grant from the National Institutes of Health (NIH) will enable an entomologist at the University of California, Riverside to study how our immune system responds to rickettsial infection.

The immune system is composed of innate and adaptive immunity. The first line of war against infectious agents is innate immunity, while adaptive immunity acts as a second line of defense and protects us against re-exposure to the same pathogen.

"If we understand how our innate immune system works during rickettsial infection, we can use this knowledge to devise novel therapeutics that delay or prevent the onset of rickettsial diseases," said Joao Pedra, the principal investigator of the five-year grant and an assistant professor of entomology.

The main types of rickettsial diseases include devastating typhus, spotted fever, and tsutsugamushi disease. Fever, chills, aches and pain are some common clinical symptoms.

Rickettsial diseases tend to be endemic in areas where public health infra-structure is poor or in tropical regions typically, the developing world. But because of climate change, arthropod vectors that transmit rickettsial agents have re-emerged in developed countries such as the United States.

In the past few decades, research has shown that blood-sucking arthropods such as ticks, mosquitoes, and lice use their saliva during feeding to dampen inflammation and coagulation, and decrease the pain associated with the bite. Consequently, when a person gets bitt
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Sex on Six Legs is focus of UC Riverside biologists book
2. UC Riverside faculty member elected fellow of Entomological Society of America
3. UC Riverside botanist receives high honor from Howard Hughes Medical Institute
4. Evolutionary geneticist to give talk at UC Riverside on how biological species evolve and adapt
5. Americans Use of Antidepressants On the Rise: Study
6. Health Plans Much Costlier for Docs in U.S. Than Canada: Study
7. Obesity Counseling Should Stress Brain, Not Willpower: Study
8. New study calls into question reliance on animal models in cardiovascular research
9. Study: Inexpensive method detects ALK rearrangement in lung cancer patients
10. Americans No Longer Outliving Europeans: Study
11. Pilot study suggests new approach to treat preeclampsia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC Riverside entomologist to study diseases transmitted by ticks
(Date:4/1/2015)... (PRWEB) April 01, 2015 Tempaper has ... a new virtual giving campaign that will raise critical ... people fighting muscle disease across the United States. , ... MDA through Tempaperdesigns.com will automatically receive free ... bring strength and urgently needed progress to children and ...
(Date:4/1/2015)... 01, 2015 eMindful , the ... of its executive team with the addition of veteran ... , In his new role, Suissa is ... interface across the business and consumer portals. He also ... the company’s online community. His hiring was a ...
(Date:4/1/2015)... 2015 Senior Helpers of Central Texas ... Provider of Choice Award by Home Care Pulse. The Best ... given to home care providers who receive the highest satisfaction ... quality in home care. This recognition reassures you that your ... provide you with quality, trustworthy in home care. , In ...
(Date:4/1/2015)... April 01, 2015 Skin cancer is one ... cured if caught early. Forefront Dermatology and Dermatology Associates of ... dangerous condition before it spreads so they are hosting a ... 11th from 8:30am - 12:30pm. , “If we can ... areas of concern, that could become cancerous,” said Dr. Ken ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Natural fertility ... Vancouver to attend the world’s first Integrative Fertility Symposium ... at Harbour Centre (SFU Downtown Campus), 515 West Hastings ... public talk Sunday, May 3rd, 3:00 pm to 5:00 ... is the first of its kind in the world ...
Breaking Medicine News(10 mins):Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 2Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 3
... Fees on Transfer of Ordinary Shares Into ADRs to be Waived ... ... York, October 31 XTL,Biopharmaceuticals Ltd. (NASDAQ: XTLB ; TASE: ... the Official List of the,United Kingdom Listing Authority, pursuant to the ...
... WESTMINSTER, Colo., Oct. 31 Allos,Therapeutics, Inc. (Nasdaq: ... commercialization of small molecule therapeutics for,the treatment of cancer, ... present a corporate overview at the 2007 Acumen BioFin ... presentation will take place at 8:50 a.m. (Eastern) on,Tuesday, ...
... Loss -, - New Drug Application Filing Planned by the End of ... ... -, SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Oct. ... LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today,announced positive ...
... ... Company, SANTA ... innovative medical devices used by interventional,radiologists and vascular surgeons for the ... disease, announced,today that it has named Dennis Rosenberg to the position ...
... 31 StemCor Systems, Inc., a,medical device ... today that it has received 510(k) clearance ... to market its MarrowMiner(TM),for the harvest of ... "Regulatory clearance of StemCor,s MarrowMiner is ...
... Alberta, Oct. 30 Medical Services,International Inc. (OTC Pink ... 4 additional distributors in the month of October, 2007. ... to purchase,a total of 750,000 test kits in the ... Fever and Malaria. There is a significant demand for,a ...
Cached Medicine News:Health News:XTL Announces Delisting From the Official List of the United Kingdom Listing Authority 2Health News:XTL Announces Delisting From the Official List of the United Kingdom Listing Authority 3Health News:Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference 2Health News:Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study 2Health News:Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study 3Health News:Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study 4Health News:Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study 5Health News:Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study 6Health News:Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study 7Health News:Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study 8Health News:Bacchus Vascular Names Dennis Rosenberg as Vice President of Marketing 2Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 2Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 3
(Date:4/1/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... $60.0 million aggregate principal amount of its convertible ... private placement to qualified institutional buyers pursuant to ... as amended (the "Act"). Egalet also granted the ...
(Date:4/1/2015)... April 1, 2015  Salix Pharmaceuticals, Ltd. ("Salix"), ... Inc. (NYSE: VRX ) (TSX:VRX), today announced ... $750,000,000 aggregate principal amount of its 6.00% Senior ... " Notes ") pursuant to two redemptions. On ... principal amount of the Notes, and on May ...
(Date:4/1/2015)... AVIV, Israel , April 1, 2015 /PRNewswire/ ... a clinical-stage biopharmaceutical company focused on the development ... the treatment of liver diseases and cholesterol gallstones, ... Tonelli as Vice President of Clinical Operations. ... progressive experience in clinical operations, development and regulatory ...
Breaking Medicine Technology:Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 2Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 3
... blood ... flow, muscle oxygen supply, HOBOKEN, N.J., Oct. 17 ... reveals Pycnogenol(R),(pic-noj-en-all), an antioxidant plant extract from the bark of the ... which leads to an increase in blood flow and oxygen supply,to ...
... vs. Drug-Eluting and Bare ... ... TRIAS (TRI-stent Adjudication Study) trial of OrbusNeich,s,Genous Bio-engineered R stent has ... to Robbert de Winter, M.D., Ph.D.,principal investigator and director of the ...
Cached Medicine Technology:New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 2New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 3Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
For the quantitative in vitro determination of Uric Acid in serum, plasma and urine...
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
For the quantitative in vitro determination of Urea in serum, plasma and urine....
Medicine Products: